NCT01432834

Brief Summary

The purpose of the study was to assess the efficacy of the Allegretto Wave excimer laser and the wavefront optimized ablation profile in correcting primarily non-anterior astigmatism faults, following laser in-situ keratomileusis (LASIK) and photorefractive keratectomy (PRK).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 13, 2011

Completed
Last Updated

January 18, 2017

Status Verified

January 1, 2017

Enrollment Period

8 months

First QC Date

September 12, 2011

Last Update Submit

January 14, 2017

Conditions

Keywords

non-anterior astigmatism correctionAllegretto Wave excimer laserwavefront optimized ablation profile (WFO)LASIKPRK

Outcome Measures

Primary Outcomes (1)

  • vector analysis of astigmatism correction, following laser in-situ keratomileusis (LASIK) & photorefractive keratectomy (PRK) treatments.

    Vector analysis of astigmatism correction was conducted using preoperative and 6-month postoperative data. The following indexes were calculated: a) Correction index (CI) which is determined by the ratio of the surgically induced astigmatism (SIA) to the target induced astigmatism (TIA), b) Difference vector (DV) as an absolute measure of success, and, c) Index of Success (IOS) which is determined by the relationship of the DV to the TIA, as a relative measure of success.

    6 months postoperatively

Study Arms (2)

LASIK group (LG group)

OTHER

Volunteers of this group received LASIK treatment.

Other: Laser in situ keratomileusis (LASIK)

PRK group (PG group)

OTHER

Volunteers of this group received PRK treatment

Other: Photorefractive keratectomy (PRK)

Interventions

During LASIK treatments the Carriazo-Pendular microkeratome (SCHWIND eye-tech-solutions GmbH \& Co.KG, Kleinostheim, Germany) with 130μm cutting head was used for the creation of the flap. The normal value of the negative pressure of the suction ring was between 600-620 mmHg and the velocity of the head movement was constant (3mm/sec). The hinge was created at the 12 o'clock position. The Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany) was used for all ablations. Attempted ablations were modified according to the "S001 Wellington" nomogram for the "wavefront optimised" protocol.

Also known as: Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany), Carriazo-Pendular microkeratome (SCHWIND eye-tech-solutions GmbH & Co.KG, Kleinostheim, Germany)
LASIK group (LG group)

The same surgical procedure was applied to all PG participants that included: Instillation of proparacaine hydrochloride 0.5% drops for topical anaesthesia, application of a sponge saturated with 10% alcohol to the central cornea for 20-30 seconds and subsequent de-epithelialization by means of a hockey knife.The Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany) was used for all ablations. Attempted ablations were modified according to the "S001 Wellington" nomogram for the "wavefront optimised" protocol. A soft therapeutic lens was applied until complete re-epithelialization of the cornea was detected.

Also known as: Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany)
PRK group (PG group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • astigmatism fault

You may not qualify if:

  • previous incisional eye surgery
  • evidence of any type of corneal pathology
  • evidence of any type of optic neuropathy
  • history of optic neuropathy
  • diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye Institute of Thrace (EIT)

Alexandroupoli, 68100, Greece

Location

Related Publications (1)

  • Labiris G, Gatzioufas Z, Giarmoukakis A, Sideroudi H, Kozobolis V. Evaluation of the efficacy of the Allegretto Wave and the Wavefront-optimized ablation profile in non-anterior astigmatisms. Acta Ophthalmol. 2012 Sep;90(6):e442-6. doi: 10.1111/j.1755-3768.2012.02463.x. Epub 2012 Jun 13.

MeSH Terms

Conditions

Astigmatism

Interventions

Keratomileusis, Laser In SituPhotorefractive Keratectomy

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

Corneal Surgery, LaserLaser TherapyTherapeuticsAblation TechniquesSurgical Procedures, OperativeKeratectomyRefractive Surgical ProceduresOphthalmologic Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer of Ophthalmology

Study Record Dates

First Submitted

September 12, 2011

First Posted

September 13, 2011

Study Start

April 1, 2010

Primary Completion

December 1, 2010

Study Completion

April 1, 2011

Last Updated

January 18, 2017

Record last verified: 2017-01

Locations